EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

IL-33 controls IL-22-dependent antibacterial defense by modulating the microbiota

Ivo Röwekamp, Laura Maschirow iD, Anne Rabes, Facundo Fiocca Vernengo, Lutz Hamann iD, Gitta Anne Heinz iD, Mir-Farzin Mashreghi iD, Sandra Caesar, Miha Milek iD, Anna Carolina Fagundes Fonseca iD, Sandra-Maria Wienhold, Geraldine Nouailles iD und 13 weitere

Proceedings of the National Academy of Sciences · 28.05.2024 · 121 (22)

DOI: 10.1073/pnas.2310864121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 23.05.2024. Verfasst von Ivo Röwekamp und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität …. Hauptthemen laut MEDLINE: Interleukin-33, Interleukins, Interleukin-22, Streptococcus pneumoniae. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG), Bundesministerium für Bildung und Forschung (BMBF), EC | ERC | HORIZON EUROPE European Research Council (ERC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IL-22 plays a critical role in defending against mucosal infections, but how IL-22 production is regulated is incompletely understood. Here, we show that mice lacking IL-33 or its receptor ST2 (IL-1RL1) were more resistant to Streptococcus pneumoniae lung infection than wild-type animals and that single-nucleotide polymorphisms in IL33 and IL1RL1 were associated with pneumococcal pneumonia in humans. The effect of IL-33 on S. pneumoniae infection was mediated by negative regulation of IL-22 production in innate lymphoid cells (ILCs) but independent of ILC2s as well as IL-4 and IL-13 signaling. Moreover, IL-33’s influence on IL-22-dependent antibacterial defense was dependent on housing conditions of the mice and mediated by IL-33’s modulatory effect on the gut microbiota. Collectively, we provide insight into the bidirectional crosstalk between the innate immune system and the microbiota. We conclude that both genetic and environmental factors influence the gut microbiota, thereby impacting the efficacy of antibacterial immune defense and susceptibility to pneumonia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-33InterleukinsInterleukin-22Streptococcus pneumoniaeImmunity, InnateInterleukin-1 Receptor-Like 1 ProteinAnimalsMiceHumansMice, KnockoutMicrobiotaMice, Inbred C57BLPneumonia, PneumococcalGastrointestinal MicrobiomeLymphocytesPolymorphism, Single Nucleotide

Stichwörter der Autor:innen

IL-22IL-33Streptococcus pneumoniaemicrobiotapneumonia

Substanzen

Interleukin-33InterleukinsInterleukin-22Interleukin-1 Receptor-Like 1 ProteinIl33 protein, mouseIl1rl1 protein, mouse

Autor:innen und Institutionen

  • Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin 13353, Germany.
  • Institute of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin 12203, Germany.
  • German Rheumatism Research Center, a Leibniz Institute, Berlin 10117, Germany.
  • Core Unit Bioinformatics, Berlin Institute of Health at Charité, Berlin 10117, Germany.
  • Research Group Infection Immunology, Institute of Medical Microbiology and Hospital Hygiene, Health Campus Immunology, Infectiology and Inflammation, Otto-von-Guericke-University, Magdeburg 39120, Germany.
  • Research Group Immune Regulation, Helmholtz Centre for Infection Research, Braunschweig 38124, Germany.

ORCID-Profile: Laura Maschirow, Lutz Hamann, Gitta Anne Heinz, Mir-Farzin Mashreghi, Miha Milek, Anna Carolina Fagundes Fonseca, Geraldine Nouailles, Ling Yao, Dunja Bruder, Julia D Boehme, Monika Puzianowska-Kuznicka, Max Löhning, Christoph S N Klose, Markus M Heimesaat, Andreas Diefenbach, Bastian Opitz

Förderung

  • Deutsche Forschungsgemeinschaft (DFG)
  • Bundesministerium für Bildung und Forschung (BMBF)
  • EC | ERC | HORIZON EUROPE European Research Council (ERC)
  • Einstein Foundation Berlin

Zitieren

APA

Röwekamp, I., Maschirow, L., Rabes, A., Fiocca Vernengo, F., Hamann, L., Heinz, G. A., Mashreghi, M. F., Caesar, S., Milek, M., Fagundes Fonseca, A. C., Wienhold, S. M., Nouailles, G., Yao, L., Mousavi, S., Bruder, D., Boehme, J. D., Puzianowska-Kuznicka, M., Beule, D., Witzenrath, M., …, & Opitz, B. (2024). IL-33 controls IL-22-dependent antibacterial defense by modulating the microbiota. Proceedings of the National Academy of Sciences, 121(22). https://doi.org/10.1073/pnas.2310864121

Vancouver

Röwekamp I, Maschirow L, Rabes A, Fiocca Vernengo F, Hamann L, Heinz GA, et al. IL-33 controls IL-22-dependent antibacterial defense by modulating the microbiota. Proceedings of the National Academy of Sciences. 2024;121(22). doi:10.1073/pnas.2310864121

BibTeX
@article{Rwekamp2024,
  author = {Röwekamp, Ivo and Maschirow, Laura and Rabes, Anne and Fiocca Vernengo, Facundo and Hamann, Lutz and Heinz, Gitta Anne and Mashreghi, Mir-Farzin and Caesar, Sandra and Milek, Miha and Fagundes Fonseca, Anna Carolina and Wienhold, Sandra-Maria and Nouailles, Geraldine and Yao, Ling and Mousavi, Soraya and Bruder, Dunja and Boehme, Julia D and Puzianowska-Kuznicka, Monika and Beule, Dieter and Witzenrath, Martin and CAPNETZ Study Group, CAPNETZ Study Group and Löhning, Max and Klose, Christoph S N and Heimesaat, Markus M and Diefenbach, Andreas and Opitz, Bastian},
  title = {IL-33 controls IL-22-dependent antibacterial defense by modulating the microbiota},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {22},
  doi = {10.1073/pnas.2310864121}
}
Kostenlos starten →